-+ 0.00%
-+ 0.00%
-+ 0.00%

Gabapentin, a subsidiary of Prologopharm (000739.SZ), obtained the European CEP certificate

Zhitongcaijing·07/22/2026 13:25:03
Listen to the news

According to the Zhitong Finance App, Prorow Pharmaceutical (000739.SZ) issued an announcement. Recently, Zhejiang Puluo Jiayuan Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the European Pharmacopeia Suitability Certificate for Gabapentin APIs (“CEP Certificate”) issued by the European Medicines Quality Administration (EDQM). Gabapentin is an artificially synthesized amino acid similar to the neurotransmitter gamma-aminobutyric acid (GABA). Indications are: 1. Neuralgia after herpes infection: for the treatment of post-herpetic neuralgia in adults; 2. Epilepsy: for adjuvant treatment of partial seizures with or without secondary generalized seizures in adults and children aged 12 and over; it can also be used as an adjuvant treatment for partial seizures in children aged 3 to 12.